ASCO’s online system will undergo routine maintenance from 5 PM (ET) Thursday, August 24, to 5 PM (ET) Monday, August 28. Certain activities will be unavailable during that time. For more information, click here.
As the worldwide death rate from hepatobiliary cancers continues to grow, Drs. Karasic and Loaiza-Bonilla explain that research must focus on finding an effective treatment—and immunotherapy could be the answer.
Dr. Jorge Gallardo and colleagues discuss the epidemiology of esophageal, gastric, liver, gallbladder, pancreatic, colon, and rectal cancers in Chile and how the country’s changing demographics across the past 20 years have increased cancer mortality rates.
Drs. Young and Chau review several early-phase studies on combination immunotherapy treatments for GI cancers and what these studies have uncovered about the certain tumor types that are responsive and those that are poorly immunogenic.